Anti-TNF-α therapies are used in clinics currently for inflammatory bowel disease and arthritis (Huang et al., 2012; Perrier and Rutgeerts, 2012), and serve as an attractive future solution to reduce reproductive pathologies induced by genital chlamydial infection. Here, TNF is linked to chlamydia trachomatis infectious disease.